Alliance Pharma launches Xonvea in the UK
2nd Oct 2018 09:56
(Sharecast News) - Alliance Pharma launched its prescription product for the treatment of nausea and vomiting of pregnancy across the UK on Tuesday.
Read moreAlliance Pharma overseas transformation continues
19th Sep 2018 09:28
(Sharecast News) - As Alliance Pharma's overseas transformation continued throughout the first half of its trading year, the AIM-listed group managed to record some growth in both revenues and profits.
Read moreAlliance Pharma on track despite currency fluctuation issues
25th Jul 2018 08:24
(Sharecast News) - Specialty pharmaceutical group Alliance Pharma said on Wednesday that it was on track to meet expectations after "strong" performances from its MacuShield, Vamousse and Kelo-Cote brands.
Read moreAlliance Pharma to more than double revenue in 2016 results
23rd Jan 2017 14:34
(ShareCast News) - Specialty pharmaceutical company Alliance Pharma announced its pre-close trading update ahead of its preliminary results for the year to 31 December on Monday. The AIM-traded firm said group revenue for 2016 was now expected to be more than double the prior year at £97.5m. It sai
Read moreAlliance Pharma H1 profit doubles after acquisition
14th Sep 2016 08:05
(ShareCast News) - Alliance Pharma posted a jump in first-half profit and revenue as it benefited from the acquisition of the Sinclair Healthcare Products business last year. In the six months to the end of June, pre-tax profit surged 113% to £11.7m on revenue of £46.4m, up 104% from the first half
Read moreAlliance Pharma sales more than double on Sinclair acquisition
19th Jul 2016 09:15
(ShareCast News) - Specialty pharmaceutical company Alliance Pharma said its sales more than doubled in the six months ended 30 June thanks to its acquisition of the Sinclair Healthcare Products business in December last year. Sales rose to £46.4m from £22.8m, with Sinclair products contributing £20
Read moreAlliance Pharma 2015 profit up on Sinclair Healthcare acquisition
7th Apr 2016 14:42
(ShareCast News) - Alliance Pharma posted a rise in 2015 pre-tax profit as revenue grew following its acquisition of the Sinclair Healthcare Products division. For the year to the end of December, pre-tax profit increased 49% to £15.2m as revenue rose 11% to £48.3m. This included £0.8m from the "tra
Read moreAlliance Pharma trading in line; confident on full-year outlook
13th Jul 2015 16:21
(ShareCast News) - Speciality pharmaceutical company Alliance Pharma said it was trading in line with expectations, with sales of around £22.8m in in the six months ended June 30, up from £21.4m in the same period last year. In a trading update ahead of its interim results, the company said its grow
Read moreAlliance Pharma appoints Andrew Franklin as finance director
10th Jul 2015 10:27
Specialty pharmaceutical company Alliance Pharma announced the appointment of Andrew Franklin as finance director with effect from 28 September 2015. Franklin joins the company from Panasonic Europe, where he was general manager, European tax and accounting. Before that, he was finance director and
Read moreTuesday tips round-up: Greene King, Alliance Pharma
20th Jan 2015 14:23
Pub operator Greene King has seen a slowdown in its sales for the fiscal year-to-date, but its recent purchase of rival Spirit Pub Company will pay off. In the 36 weeks since the start of the financial year like-for-like sales were ahead by 0.6%, a mediocre result, even if it was partially due to to
Read moreWednesday broker round-up UPDATE
24th Sep 2014 09:15
Aggreko: Morgan Stanley ups target price from 1350p to 1375p, while leaving its underweight rating unaltered. Alliance Pharma: Canaccord Genuity lowers target price from 35p to 33p reiterating its hold recommendation. Close Brothers Group: UBS moves target price from 1420p to 1430p and keeps a neut
Read moreWednesday broker round-up UPDATE
21st May 2014 08:36
African Minerals: Citi reduces target price from 260p to 190p, while leaving its buy recommendation unchanged. Alliance Pharma: Numis lowers target price from 39p to 37p and maintains an add rating. APR Energy: JP Morgan shifts target price from 1082p to 1089p keeping its overweight rating. Astra
Read moreAlliance Pharma's 2013 pre-tax profit rises
26th Mar 2014 16:09
Alliance Pharma's annual pre-tax profit gained 11 per cent to 12m pounds, on the back of three acquisitions. The pharmaceutical company reported a 1.4% rise in revenue to £45.5m and a 6% increase in earnings per share to 3.82p. The company said growth was "underpinned by the continuing success o
Read moreWednesday broker round-up UPDATE
26th Mar 2014 08:51
Aberdeen Asset Management: Citi reduces target price from 455p to 390p and stays with its neutral rating. Acta: Cantor Fitzgerald places both its target price (prev.: 16p) and its buy recommendation under review. Alliance Pharma: Numis shifts target price from 38p to 39p upgrading to add. APR Ene
Read moreAlliance Pharma returns to double-digit profit growth
26th Mar 2014 07:30
- Returns to double-digit profit growth in 2013 - Revenue growth held back by production issues with ImmuCyst - Confident of future growth, eyes more acquisitions AIM-listed drug company Alliance Pharma said it is confident of good revenue and profit momentum over the next few years as it posted do
Read more